Prediction of respiratory outcome in extremely low gestational age infants

Richard B Parad1, Jonathan M Davis, Jessica Lo

  • 1Department of Pediatric Newborn Medicine, Brigham and Women's Hospital, Boston, Mass., USA.

Neonatology
|March 14, 2015
PubMed

Insights

Respiratory morbidity (RM) at 12 months corrected age better predicts later respiratory issues in extremely preterm infants than bronchopulmonary dysplasia (BPD). This finding aids in assessing long-term respiratory health in high-risk neonates.

Area of Science:

  • Neonatal Medicine
  • Pediatric Pulmonology
  • Clinical Trial Outcomes

Background:

  • Bronchopulmonary dysplasia (BPD) is a standard outcome measure in neonatal clinical trials.
  • Accurate prediction of long-term respiratory health in extremely preterm infants remains a challenge.

Purpose of the Study:

  • To compare the predictive accuracy of BPD diagnosis versus respiratory morbidity (RM) at 12 months corrected age for subsequent respiratory outcomes.
  • To evaluate RM definitions (RM1, RM2) and BPD (at 28 days and 36 weeks) in predicting respiratory health at 24 months corrected age.

Main Methods:

  • Development and validation cohorts of extremely low gestational age infants (23-28 weeks).
  • Pulmonary function tests and parental respiratory diaries at 12 months corrected age.
  • Assessment of BPD at 28 days and 36 weeks post-menstrual age.
  • Evaluation of RM1 and RM2 based on weekly diary entries for 2 weeks.
  • Prediction of respiratory outcomes at 24 months using health questionnaires.

Main Results:

  • BPD diagnoses (BPD28d, BPD36w) did not significantly predict any respiratory outcome at 24 months.
  • Respiratory morbidity (RM1, RM2) assessed via parental diaries showed significantly better predictive performance than BPD.
  • Receiver operating characteristic curve analysis confirmed superior predictive value for RM definitions.

Conclusions:

  • Respiratory morbidity, as documented by parental diaries at 12 months corrected age, is a superior predictor of respiratory outcomes at 24 months corrected age compared to BPD.
  • These findings suggest refining outcome measures in neonatal trials for extremely preterm infants.
Abstract

Related Concept Videos

Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
686
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
1.6K
Assessment of Ventilation I: Respiratory Rate01:20

Assessment of Ventilation I: Respiratory Rate

Assessment of Ventilation
A Ventilation assessment is critical for monitoring a patient's health status. Respiration, one of the most accessible vital signs, provides insights into the function of numerous body systems and can indicate serious health issues, such as brainstem injuries from head trauma.
Critical Guidelines for Assessing Ventilation:
2.9K
Respiratory Assessment: Purpose and Indications01:19

Respiratory Assessment: Purpose and Indications

Respiratory assessment is a cornerstone of nursing assessments, crucial for the early detection of patient deterioration. This evaluation transcends routine procedures, representing a critical skill nurses must master to ensure optimal patient care.
Objectives and Importance:
The primary goal of respiratory assessment is to evaluate patients at early risk of clinical deterioration. Since respiratory distress often precedes other signs of declining health, breathing patterns and sounds become a...
2.1K
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
1.2K
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
1.6K